Abdulla Shehab*, Khalid F. AlHabib , Akshaya S. Bhagavathula , Ahmad Hersi , Hussam Alfaleh, Mostafa Q. Alshamiri , Anhar Ullah , Khadim Sulaiman, Wael Almahmeed , Jassim Al Suwaidi , Alwai A. Alsheikh-Ali , Haitham Amin , Mohammed Al Jarallah and Amar M. Salam
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study
Dimitri P. Mikhailidis Academic Head, Department of Clinical Biochemistry Royal Free Hospital Campus University College London Medical School University College London (UCL) Pond Street London, NW3 2QG UK
Dimitri P. Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School. He is also a Visiting Professor, University of Belgrade, Serbia and at two universities in Saudi Arabia. His research interests are dyslipidaemias and thrombosis.
He is a Fellow of the Royal College of Pathologists (FRCPath), Royal College of Physicians (FRCP), Faculty of Pharmaceutical Medicine (FFPM) and American College of Clinical Pharmacology (FCP). He has 22,093 citations on the ISI index, Core Collection (H-factor 64).